梁曦，女，博士。bat365官网登录入口营养与食品卫生学系助理教授，青年卓越人才。本科毕业于哈尔滨医科大学预防医学专业，硕士毕业于哈尔滨医科大学营养与食品卫生学，2022年毕业于中国海洋大学食品科学与工程学院。主持山东省自然科学基金青年项目1项，青岛市博后创新项目1项。发表文章20余篇，其中以第一作者在《Food Science and Human Wellness》《LWT - Food Science and Technology》《Food & Function》等权威期刊累计发表研究论文6篇；授权发明专利1项；参编专著1部；担任《Frontier in Microbiology》学术期刊评审编辑。
一、主要研究方向
益生菌功效成分挖掘
营养与代谢病
二、代表性科研成果
(1)Xi Liang; Youyou Lv; Zhe Zhang; Huaxi Yi; Tongjie Liu; Rui Li; Zhuang Yu; Lanwei Zhang ;Study on intestinal survival and cholesterol metabolism of probiotics, LWT-FOOD SCIENCE ANDTECHNOLOGY, 2020, 124: 109132
(2)Xi Liang; Zhe Zhang; Xiaohong Zhou; Youyou Lu; Rui Li; Zhuang Yu; Lingjun Tong; PiminGong; Huaxi Yi; Tongjie Liu; Lanwei Zhang ; Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR, FOOD & FUNCTION, 2020, 11(11): 9903-9911
(3)Xi Liang; Zhe Zhang; Youyou Lv; Linjun Tong; Tongjie Liu; Huaxi Yi; Xiaohong Zhou; ZhuangYu; Xiaoying Tian; Qingyu Cui; Jiebing Yang; Pimin Gong; Lanwei Zhang ; Reduction of intestinaltrimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis, NUTRITION, 2020, 79-80: 110941
(4)Xi Liang; Xiumei Zheng; Peng Wang; Huaqi Zhang; Yiqing Ma; Hui Liang; Zhe Zhang; Bifidobacterium animalis subsp. lactis F1–7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR, Journal of Agricultural and Food Chemistry, 2024, 72(5): 2585-2597
(5)Xi Liang; Zhe Zhang; Xiaoying Tian; Qingyu Cui; Haiyan Lu; Maozhen Zhao; Tongjie Liu;Huaxi Yi; Pimin Gong; Lanwei Zhang; Metabolite acetyl-L-carnitine participates in Bifidobacterium animalis F1-7 to ameliorate atherosclerotic inflammation by downregulating the TLR4/NF-κB pathway, Food Science and Human Wellness, 2024, 13(2): 813-822
三、主要科研项目
（1）动物双歧杆菌F1-7参与胆汁酸代谢调控肠道靶点FXR改善动脉粥样硬化的效应机制探究，山东省自然科学基金青年项目, 15万元，2024-2026，主持
（2）动物双歧杆菌F1-7参与胆汁酸代谢调控肠肝轴改善动脉粥样硬化的效应机制探究，青岛市博士后创新项目，5万元，2023-2025，主持
四、联系方式
E-mail: liangxi6029@163.com
